NL-OMON21944招募中不适用
The effect on embryo-quality of rLH-addition to rFSH for controlled ovarian hyperstimulation in women with poor ovarian reserve
MerckSerono0 个研究点目标入组 220 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 220
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients between 35 and 43 years of age
- •2. Patients with IOF, <35 years
排除标准
- •Endocrinopathological disease as: Cushing’s syndrome, adrenal hyperplasia, hyperprolactinaemia, acromegaly, hypothalamic amenorrhea, hypothyroidy, diabetes mellitus type I, PCOS
- •If not willing or able to sign the informed consent form
研究者
相似试验
尚未招募
不适用
The effect on embryo-quality of rLH-addition to rFSH for controlled ovarian hyperstimulation in women with poor ovarian reservesubfertility1001470110013356NL-OMON31586Academisch Medisch Centrum220
已完成
4 期
The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)Pregnancy Result RapeNCT01016210The Baruch Padeh Medical Center, Poriya60
已完成
4 期
Nordic Luveris StudyIn Vitro FertilizationInfertilityNCT00553293Rigshospitalet, Denmark526
已完成
4 期
The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSIInfertilityNCT02108223Sisli Hamidiye Etfal Training and Research Hospital137
已完成
不适用
Does the addition of Recombinant Luteinising Hormone (recLH) (Luveris) to a regimen of Recombinant Follicle Stimulating Hormone (recFSH) (Gonal-F) and Gonadotropin Releasing Hormone (GnRH) antagonist (Cetrotide) improve ovarian response and implantation rates in patients age >35 years undergoing in vitro fertilisation (IVF)/embryo transfer (ET)?SubfertilityUrological and Genital DiseasesFemale infertilityISRCTN10841210VU University Medical Centre (VUMC) (Netherlands)600